These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37865547)

  • 21. Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015;16:76-86.
    Ohlmann CH; Stöckle M
    Eur Urol; 2015 Dec; 68(6):1104-5. PubMed ID: 26320378
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8.
    Ennis RD; Hu L; Ryemon SN; Lin J; Mazumdar M
    Eur Urol Oncol; 2019 Mar; 2(2):226-227. PubMed ID: 31017102
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052-68: The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.
    Seisen T; Babjuk M; Rouprêt M
    Eur Urol; 2017 Apr; 71(4):e111-e112. PubMed ID: 27666997
    [No Abstract]   [Full Text] [Related]  

  • 24. Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer.
    Ericson KJ; Murthy PB; Bryk DJ; Ramkumar RR; Broughman JR; Khanna A; Mian OY; Campbell SC
    Clin Adv Hematol Oncol; 2019 Dec; 17(12):697-707. PubMed ID: 31851158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting.
    Vetterlein MW; Rink M
    Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
    Contieri R; Hensley PJ; Kamat AM
    Eur Urol Oncol; 2024 Apr; 7(2):301. PubMed ID: 37806840
    [No Abstract]   [Full Text] [Related]  

  • 27. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
    Thompson IM
    J Urol; 2001 Aug; 166(2):630. PubMed ID: 11458100
    [No Abstract]   [Full Text] [Related]  

  • 29. Robotic Female Radical Cystectomy.
    Truong H; Maxon V; Goh AC
    J Endourol; 2021 Sep; 35(S2):S106-S115. PubMed ID: 34499552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399-405.
    Nguyen DP; Scherr DS
    Eur Urol; 2016 Mar; 69(3):e36. PubMed ID: 26187784
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
    Briganti A; Gandaglia G; Graefen M; Joniau S; Karnes RJ; Montorsi F
    Eur Urol; 2021 May; 79(5):e154-e156. PubMed ID: 33637367
    [No Abstract]   [Full Text] [Related]  

  • 32.
    Tzelves L; Skolarikos A; Mourmouris P; Lazarou L; Kostakopoulos N; Manatakis DK; Kural AR
    J Endourol; 2019 Dec; 33(12):986. PubMed ID: 31829909
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution.
    Kwon T; Jeong IG; You D; Hong B; Hong JH; Ahn H; Kim CS
    J Korean Med Sci; 2014 May; 29(5):669-75. PubMed ID: 24851023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Vejlgaard M, Maibom SL, Stroomberg HV, et al. Long-term Renal Function Following Radical Cystectomy for Bladder Cancer. Urology. 2021;S0090-4295(21)01083-9. doi:10.1016/j.urology.2021.11.015.
    Ghoreifi A; Djaladat H
    Urology; 2022 Jun; 164():300. PubMed ID: 35227711
    [No Abstract]   [Full Text] [Related]  

  • 35. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.
    Asadauskiene J; Aleknavicius E; Pipiriene-Zelviene T; Jankevicius F
    Medicina (Kaunas); 2010; 46(5):305-14. PubMed ID: 20679745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
    Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
    Urol Oncol; 2019 Dec; 37(12):893-899. PubMed ID: 31296422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy).
    Castagnetti M; Herbst KW; Esposito C
    Curr Opin Urol; 2019 Sep; 29(5):487-492. PubMed ID: 31188163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525-36: Blood Loss in Robot-assisted Radical Cystectomy: An Important Patient Benefit.
    Abeysiri S; Richards T
    Eur Urol; 2019 Feb; 75(2):e36. PubMed ID: 30268660
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurovascular preservation in female orthotopic radical cystectomy significantly improves sexual function.
    Nandipati KC; Bhat A; Zippe CD
    Urology; 2006 Jan; 67(1):185-6. PubMed ID: 16413361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.